These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7510691)

  • 21. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene.
    Yasumoto K; Okamoto S; Mukaida N; Murakami S; Mai M; Matsushima K
    J Biol Chem; 1992 Nov; 267(31):22506-11. PubMed ID: 1331059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
    Ivanov V; Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of NF(P), the nuclear factor that interacts with the regulatory P sequence (5'-CGAAAATTTCC-3') of the human interleukin-4 gene: relationship to NF-kappa B and NF-AT.
    Matsuda I; Masuda ES; Tsuboi A; Behnam S; Arai N; Arai K
    Biochem Biophys Res Commun; 1994 Mar; 199(2):439-46. PubMed ID: 8135784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ETS1 transactivates the human GM-CSF promoter in Jurkat T cells stimulated with PMA and ionomycin.
    Thomas RS; Tymms MJ; Seth A; Shannon MF; Kola I
    Oncogene; 1995 Nov; 11(10):2135-43. PubMed ID: 7478534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NF-kappa B p65 promoter.
    Ueberla K; Lu Y; Chung E; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):227-30. PubMed ID: 8450395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of interleukin-2 gene expression by CD69-generated signals.
    D'Ambrosio D; Trotta R; Vacca A; Frati L; Santoni A; Gulino A; Testi R
    Eur J Immunol; 1993 Nov; 23(11):2993-7. PubMed ID: 8223876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation.
    Qiu D; Zhao G; Aoki Y; Shi L; Uyei A; Nazarian S; Ng JC; Kao PN
    J Biol Chem; 1999 May; 274(19):13443-50. PubMed ID: 10224109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
    Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
    Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.
    Khalaf H; Jass J; Olsson PE
    BMC Immunol; 2010 May; 11():26. PubMed ID: 20507572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
    Merola M; Blanchard B; Tovey MG
    J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation.
    Novak TJ; Chen D; Rothenberg EV
    Mol Cell Biol; 1990 Dec; 10(12):6325-34. PubMed ID: 2174106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.
    Hiscott J; Marois J; Garoufalis J; D'Addario M; Roulston A; Kwan I; Pepin N; Lacoste J; Nguyen H; Bensi G
    Mol Cell Biol; 1993 Oct; 13(10):6231-40. PubMed ID: 8413223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
    Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
    Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
    Matsusaka T; Fujikawa K; Nishio Y; Mukaida N; Matsushima K; Kishimoto T; Akira S
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10193-7. PubMed ID: 8234276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-beta site.
    Doyle GA; Pierce RA; Parks WC
    J Biol Chem; 1997 May; 272(18):11840-9. PubMed ID: 9115242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of activation of transcription factor AP-1 by CD28 signalling in human T-cells.
    Los M; Dröge W; Schulze-Osthoff K
    Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):119-23. PubMed ID: 8067997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.
    Ondrey FG; Dong G; Sunwoo J; Chen Z; Wolf JS; Crowl-Bancroft CV; Mukaida N; Van Waes C
    Mol Carcinog; 1999 Oct; 26(2):119-29. PubMed ID: 10506755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.